Polypharmacy in primary care practices: An analysis using a large health insurance database

Pharmacoepidemiology and Drug Safety

Volumn 18, Issue 12, 2009, Pages 1206-1213

  Grimmsmann, Thomas ^a   Himmel, Wolfgang ^b  

^a Medical Review Board of the Statutory Health Insurance Funds Mecklenburg Vorpommern   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Databases; Drug utilisation review; Family practice; Polypharmacy; Prescriptions

Indexed keywords

ANALGESIC AGENT; ANTACID AGENT; ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; ANTILIPEMIC AGENT; ANTIRHEUMATIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARDIAC AGENT; DECONGESTIVE AGENT; DIURETIC AGENT; HORMONES AND AGENTS ACTING ON THE ENDOCRINE SYSTEM; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; FEMALE; GENERAL PRACTICE; GERMANY; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; POLYPHARMACY; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SEX RATIO;

AGE DISTRIBUTION; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FAMILY PRACTICE; FEMALE; GERMANY; HUMANS; INSURANCE, HEALTH; MALE; PHYSICIAN'S PRACTICE PATTERNS; POLYPHARMACY; PRIMARY HEALTH CARE; SEX DISTRIBUTION;

EID: 72449204170     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1841     Document Type: Article

References (26)

1. Colley CA, Lucas LM. Polypharmacy: the cure becomes the disease. J Gen Intern Med 1993; 8: 278-283.
2. Bjerrum L, Søgaard J, Hallas J, Kragstrup J. Polypharmacy: correlations with sex, age and drug regimen. A prescription database study. Eur J Clin Pharmacol 1998; 54: 197-202.
3. Viktil KK, Blix HS, Moger TA, Reikvam A. Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems. Br J Clin Pharmacol 2007; 63: 187-195. (Pubitemid 46072105)
4. Rottlaender D, Scherner M, Schneider T, Erdmann E. Polypharmacy, compliance and non-prescription medication in patients with cardiovascular disease in Germany [in German]. Dtsch Med Wochenschr 2007; 132: 139-144. (Pubitemid 46405884)
5. Veehof L, Stewart R, Haaijer-Ruskamp F, Jong BM. The development of polypharmacy. A longitudinal study. Fam Pract 2000; 17: 261-267.
6. Jörgensen T, Johansson S, Kennerfalk A, Wallander MA, Svärdsudd K. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother 2001; 35: 1004-1049.
7. Haider SI, Johnell K, Weitoft GR, Thorslund M, Fastbom J. The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600 000 older people. JAGS 2009; 57: 62-69.
8. Aronson JK. In defence of polypharmacy (editors' view). Br J Clin Pharmacol 2004; 57: 119-120.
9. Gurwitz JH. Polypharmacy: a new paradigm for quality drug therapy in the elderly? Arch Intern Med 2004; 164: 1957-1959.
10. Viktil KK, Blix HS, Reikvam A. The Janus face of polypharmacy- overuse versus underuse of medication. Norsk Epidemiologi 2008; 18(2): 147-152. (Pubitemid 351859937)
11. Kuijpers MA, van Marum RJ, Egberts AC, Jansen PA. OLDY study group. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol 2008; 65: 130-133.
12. Junius-Walker U, Theile G, Hummers-Pradier E. Prevalence and predictors of polypharmacy among older primary care patients in Germany. Fam Pract 2007; 24: 14-19. (Pubitemid 46454660)
13. Bjerrum L, Søgaard J, Hallas J, Kragstrup J. Polypharmacy in general practice: differences between practitioners. Br J Gen Pract 1999; 49: 195-198. (Pubitemid 29119093)
14. Fincke BG, Snyder K, Cantillon C, et al. Three complementary definitions of polypharmacy: methods, application and comparison of findings in a large prescription database. Pharmacoepidemiol Drug Saf 2005; 14: 121-128. (Pubitemid 40253621)
15. Blumenstock G, Balke K, Gibis B, von Stillfried D, Walter A, Selbmann HK. Statutory ambulatory medical care through the eyes of the health insurance beneficiaries - Methods and results of the 2006 NASHIP health insurance beneficiary survey: care utilisation, primary care and emergency medical services [in German]. Gesundheitswesen 2009; 71: 94-101.
16. Grimmsmann T, Schwabe U, Himmel W. The influence of hospitalisation on drug prescription in primary care-a large-scale follow-up study. Eur J Clin Pharmacol 2007; 63: 783-790. (Pubitemid 47052053)
17. Garattini L, Ghislandi S. Off-patent drugs in Italy. A short-sighted view? Eur J Health Econ 2006; 7(1): 79-83.
18. Schwabe U. Patentgeschützte Analogpräparate (Me-too-Liste 2007). On behalf of the KV Nordrhein and the nordrheinischen Krankenkassen (Stand: 22.11.2007). http://www.kvno.de/mitglieder/arznmitl/arznarch/ arznarch06/arin0612/me-too.html
19. Pearce N. Effect measures in prevalence studies. Environ Health Perspect 2004; 112(10): 1047-1050.
20. Vedsted P, Sørensen HT, Mortensen JT. Drug prescription for adult frequent attenders in Danish general practice: a population-based study. Pharmacoepidemiol Drug Saf 2004; 13: 717-724. (Pubitemid 39378281)
21. Mand P, Wilkening K, Kersting M, Hoy L, Hummers-Pradier E. Therapy with polypharmacy and inadequate medication in elder patients in general practice [in German]. Paper held at the 41. Congress of the German Society of General Practice and Family Medicine, Berlin 2007. Z Allgemeinmed 2007; 82(Congress abstracts): 1.
22. McCormick JS. Drugs and placebos in general practice. In Rational Pharmacotherapy in General Practice, Kochen MM (ed.). Springer: Berlin, 1991; 227-231.
23. Colmenero F, Sullivan SD, Palmer JA, et al. Quality of clinical and economic evidence in dossier formulary submissions. Am J Manag Care 2007; 13(7): 401-407. (Pubitemid 47080802)
24. Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors. Br Med J 2008; 336: 2-3.
25. Macfarlane J, Holmes W, Macfarlane R, Britten N. Influence of patients' expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study. Br Med J 1997; 315(7117): 1211-1214. (Pubitemid 27478217)
26. Omar RZ, O'Sullivan C, Petersen I, Islam A, Majeed A. A model based on age, sex, and morbidity to explain variation in UK general practice prescribing: cohort study. Br Med J 2008; 337: a238.